REINFOR Trademark

Trademark Overview

On Thursday, January 15, 2009, a trademark application was filed for REINFOR with the United States Patent and Trademark Office. The USPTO has given the REINFOR trademark a serial number of 77650537. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 27, 2019. This trademark is owned by Glaxo Group Limited. The REINFOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
reinfor

General Information

Serial Number77650537
Word MarkREINFOR
Filing DateThursday, January 15, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 27, 2019
Registration Number4293805
Registration DateTuesday, February 26, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
Translation of Words in MarkThe wording "REINFOR" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, September 27, 2019CANCELLED SEC. 8 (6-YR)
Monday, February 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 26, 2013REGISTERED-PRINCIPAL REGISTER
Monday, January 21, 20131(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, January 21, 2013NOTICE OF ALLOWANCE CANCELLED
Sunday, January 20, 2013TEAS DELETE 1(B) BASIS RECEIVED
Thursday, August 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 1, 2012EXTENSION 5 GRANTED
Thursday, July 19, 2012EXTENSION 5 FILED
Thursday, July 19, 2012TEAS EXTENSION RECEIVED
Friday, January 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2012EXTENSION 4 GRANTED
Friday, January 13, 2012EXTENSION 4 FILED
Friday, January 13, 2012TEAS EXTENSION RECEIVED
Saturday, July 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 8, 2011EXTENSION 3 GRANTED
Wednesday, July 6, 2011EXTENSION 3 FILED
Wednesday, July 6, 2011TEAS EXTENSION RECEIVED
Tuesday, December 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2010EXTENSION 2 GRANTED
Monday, December 6, 2010EXTENSION 2 FILED
Monday, December 6, 2010TEAS EXTENSION RECEIVED
Friday, August 13, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2010EXTENSION 1 GRANTED
Thursday, July 8, 2010EXTENSION 1 FILED
Thursday, August 12, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 8, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 26, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 3, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2009PUBLISHED FOR OPPOSITION
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 29, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 25, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 3, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 3, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 3, 2009ASSIGNED TO LIE
Friday, August 28, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 27, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 27, 2009NON-FINAL ACTION E-MAILED
Friday, March 27, 2009NON-FINAL ACTION WRITTEN
Friday, March 27, 2009ASSIGNED TO EXAMINER
Wednesday, January 21, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

reinfor pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic